公司概覽
業務類別 Biotechnology
業務概覽 Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.
公司地址 5627 Oberlin Drive, Suite 120, San Diego, CA, USA, 92121
電話號碼 +1 619 330-5499
傳真號碼 --
公司網頁 https://www.iambic.ai
員工數量 171
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Michael Secora, PhD Principal Accounting Officer, Chief Financial Officer and Chief Corporate Development Officer -- 21/09/2026
Dr. Neil Josephson, M.D. Chief Medical Officer -- 21/09/2026
Dr. Thomas Miller, PhD Chief Executive Officer and Director 美元 572.46K 21/09/2026
Dr. Frederick Manby, PhD Chief Technology Officer and Director -- 21/09/2026
Dr. Peter Olson, PhD Chief Scientific Officer -- 21/09/2026
 
董事會成員
董事會 職務 更新日期
Dr. Mary A. Tagliaferri, M.D. Independent Director 21/09/2026
Ms. Shalini Sharp, M.B.A. Independent Director 21/09/2026
Dr. William H. Rastetter,PhD Independent Director 21/09/2026
Dr. Samit Hirawat, M.D. Independent Director 21/09/2026
Dr. Thomas Miller, PhD Chief Executive Officer and Director 21/09/2026
Dr. Frederick Manby, PhD Chief Technology Officer and Director 21/09/2026
Dr. Evan Rachlin, M.D. Independent Director 21/09/2026
Dr. R. Jacob Vogelstein, PhD Independent Director 21/09/2026
Mr. Kurt von Emster Independent Director 21/09/2026
 
所屬ETF (更新日期: 07/11/2026 02:18)
代號 名稱 佔比% ▼ 持有日期
ARKGARK Genomic Revolution ETF2.88%29/10/2026
CANCTema Oncology ETF0.08%30/10/2026
HLTHTema Healthcare AI ETF0.02%30/10/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.